DADC
IONS icon

D.A. Davidson & Co’s Ionis Pharmaceuticals IONS Stock Holding History

D.A. Davidson & Co’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-48,172
Closed -$3.91M – 1077
2019
Q1 		$3.91M Sell
48,172
-1,535
-3% -$99K 0.07% 226
2018
Q4 		$2.69M Sell
49,707
-704
-1% -$35.9K 0.05% 272
2018
Q3 		$2.6M Buy
50,411
+75
+0.1% +$3.52K 0.05% 302
2018
Q2 		$2.1M Sell
50,336
-449
-0.9% -$19.9K 0.04% 335
2018
Q1 		$2.24M Buy
50,785
+226
+0.4% +$11.5K 0.05% 305
2017
Q4 		$2.54M Sell
50,559
-370
-0.7% -$20.3K 0.05% 279
2017
Q3 		$2.58M Sell
50,929
-28
-0.1% -$1.47K 0.05% 309
2017
Q2 		$2.59M Sell
50,957
-55
-0.1% -$2.56K 0.06% 258
2017
Q1 		$2.05M Sell
51,012
-1,361
-3% -$61.1K 0.05% 293
2016
Q4 		$2.5M Buy
52,373
+20,859
+66% +$825K 0.06% 306
2016
Q3 		$1.15M Sell
31,514
-42
-0.1% -$1.31K 0.03% 431
2016
Q2 		$733K Sell
31,556
-2,796
-8% -$90.2K 0.02% 457
2016
Q1 		$1.39M Buy
34,352
+17,872
+108% +$726K 0.04% 346
2015
Q4 		$1.02M Sell
16,480
-110
-0.7% -$5.94K 0.03% 392
2015
Q3 		$668K Buy
16,590
+371
+2% +$19.2K 0.02% 459
2015
Q2 		$931K Buy
16,219
+664
+4% +$42.2K 0.03% 422
2015
Q1 		$989K Sell
15,555
-6,482
-29% -$440K 0.03% 408
2014
Q4 		$1.36M Sell
22,037
-7,409
-25% -$366K 0.04% 349
2014
Q3 		$1.14M Buy
29,446
+1,648
+6% +$58.4K 0.04% 391
2014
Q2 		$956K Buy
27,798
+11,979
+76% +$377K 0.03% 440
2014
Q1 		$682K Sell
15,819
-3,988
-20% -$193K 0.02% 513
2013
Q4 		$787K Buy
19,807
+1,136
+6% +$40.5K 0.03% 466
2013
Q3 		$699K Buy
18,671
+479
+3% +$14.3K 0.03% 426
2013
Q2 		$488K Buy
+18,192
New +$387K 0.02% 482

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.A. Davidson & Co's IONS Position: Q2 2019 in Review

D.A. Davidson & Co sold out of Ionis Pharmaceuticals (IONS) in Q2 2019, closing a stake of 48,172 shares — an estimated $3.91M sold.

D.A. Davidson & Co first reported a position in IONS in Q2 2013 and held it in 24 quarters. The position peaked at $3.91M in Q1 2019. 396 funds tracked by Wall St. Rank hold IONS as of Q2 2019.

  • D.A. Davidson & Co reported no remaining Ionis Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • D.A. Davidson & Co sold 48,172 Ionis Pharmaceuticals shares in Q2 2019, an estimated $3.91M.
  • D.A. Davidson & Co first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 24 quarters.
  • D.A. Davidson & Co's Ionis Pharmaceuticals position peaked at $3.91M in Q1 2019.
  • 396 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2019.

Based on D.A. Davidson & Co's 13F filing for Q2 2019, filed 13 Aug 2019.